Maxidex, eye drops 0.1%, 5ml

Composition

In 1 ml of suspension-eye drops 0.1% contains:

Active ingredients:

dexamethasone 1 mg.

Auxiliary substances:

hydroxypropylmethylcellulose-0.5%;

distilled water;

preservative: benzalkonium chloride-0.01%.

Pharmacological action

CORTICOSTEROIDS for topical use in ophthalmology. It has a pronounced anti-inflammatory, anti-allergic and desensitizing effect. Dexamethasone actively suppresses inflammatory processes, inhibiting the release of inflammatory mediators by eosinophils, mast cell migration, and reducing capillary permeability.

The drug does not have mineralocorticoid activity.

Indications

• Allergic diseases blepharitis, conjunctivitis, keratoconjunctivitis.
• Acute iritis.
• Chronic iritis.
• Iridocyclitis.
• Prevention and treatment of inflammatory reactions in the postoperative period.
• Thermal and chemical burns (after complete epithelialization of corneal defects).

Use during pregnancy and lactation

During pregnancy, Maxidex is prescribed only in cases where the expected therapeutic effect exceeds the potential risk to the fetus or child.

For the period of use of the drug during lactation, breastfeeding should be interrupted.

 Use in children

Currently, the safety and efficacy of the drug in children have not been established.

Contraindications

• Hypersensitivity to the components of the drug.
• Viral, bacterial and fungal infections of the eyes.
• Diseases of the cornea in combination with epithelial defects.

Side effects

From the side of the organ of vision: with prolonged topical application of corticosteroids, there may be: increased intraocular pressure with possible subsequent development of glaucoma; formation of posterior subcapsular cataracts; slowing of the wound healing process (in diseases that cause thinning of the cornea or sclera, perforation of the fibrous membrane is possible).

After the use of drugs containing corticosteroids, the development of a secondary infection (including fungal) may occur, as a result of the suppression of the patient’s protective reaction.

In acute purulent diseases of the eye, corticosteroids can mask or enhance the existing infectious process. The appearance of non-healing ulcers on the cornea after prolonged treatment with steroid drugs may indicate the development of fungal invasion.

Interaction

The drug interaction of Maxidex with other drugs has not been established.

How to take, course of use and dosage

Into the conjunctival sac.

The drug is instilled in 1-2 drops of the affected eye (or eyes) every 3-6 hours.

Overdose

Currently, no overdose cases of Maxidex have been reported.

Special instructions

• During treatment, it is not recommended to wear contact lenses.
• If the drug is used for more than 10 days, the intraocular pressure should be measured regularly.
• The drug is intended for topical use only (not for injection).
• Avoid touching the tip of the dropper to any surface to avoid microbial contamination of the contents of the bottle.
• Shake the contents of the bottle before use.

Form of production

Maxidex. Eye drops.

Expiration date

Shelf life-3 years. After opening the bottle, the drug should be used for 4 weeks.

Active ingredient

Dexamethasone

Conditions of release from pharmacies

By prescription

Dosage form

eye drops

Description

For adults

Indications

Blepharitis, Eye Burn, Conjunctivitis, Iridocyclitis, Barley on the eye